| Literature DB >> 27851961 |
Ricardo Gargini1, Maribel Escoll2, Esther García3, Ramón García-Escudero4, Francisco Wandosell5, Inés María Antón6.
Abstract
In cancer, the deregulation of growth signaling pathways drives changes in the cell's architecture and its environment that allow autonomous growth of tumors. These cells then acquire a tumor-initiating "stemness" phenotype responsible for disease advancement to more aggressive stages. Here, we show that high levels of the actin cytoskeleton-associated protein WIP (WASP-interacting protein) correlates with tumor growth, both of which are linked to the tumor-initiating cell phenotype. We find that WIP controls tumor growth by boosting signals that stabilize the YAP/TAZ complex via a mechanism mediated by the endocytic/endosomal system. When WIP levels are high, the β-catenin Adenomatous polyposis coli (APC)-axin-GSK3 destruction complex is sequestered to the multi-vesicular body compartment, where its capacity to degrade YAP/TAZ is inhibited. YAP/TAZ stability is dependent on Rac, p21-activated kinase (PAK) and mammalian diaphanous-related formin (mDia), and is Hippo independent. This close biochemical relationship indicates an oncogenic role for WIP in the physiology of cancer pathology by increasing YAP/TAZ stability.Entities:
Keywords: Hippo pathway; WIPF1; YAP/TAZ; actin dynamics; breast cancer; glioma; multivesicular body; proliferation; tumor initiating cell; β-catenin destruction complex
Mesh:
Substances:
Year: 2016 PMID: 27851961 DOI: 10.1016/j.celrep.2016.10.064
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423